From Promise to Proof: Personalized Melanoma mRNA Vaccine Delivers Phase III Success
Results from a phase III trial showed that a cancer vaccine can improve outcomes for certain patients with melanoma,...
Category: Research
Results from a phase III trial showed that a cancer vaccine can improve outcomes for certain patients with melanoma,...
At the recent AACR Conference on Pancreatic Cancer, researchers explored the complex interactions among tumor cells, neurons, and the...
At the recent AACR Conference on Pancreatic Cancer, Kevan M. Shokat, PhD, FAACR, received the 2026 Stephenson Global Prize...
Salivary gland cancer is rare, and there are no standard treatments for advanced-stage disease. Recent research supports the use...
During the opening plenary session of the AACR Special Conference in Cancer Research: Bridging Discovery and Clinical Impact in...
This year’s Party with a Purpose, hosted by the Friends of the AACR Foundation, will honor Robert H. Vonderheide,...
In memory of those who lost their lives or families as a result of what happened on September 11,...
Cancer Research Catalyst has launched a new monthly series, “Unboxing Cancer News,” that highlights exciting cancer research discoveries. Read...
Featuring insights from Carl H. June, MD, FAACR, this post covers the ongoing challenges facing CAR T-cell therapy and...
Antibody-drug conjugates, or ADCs, have emerged as a significant class of cancer therapies over the past two decades. New...